A joint statement on the voluntary scheme for branded medicines pricing and access (VPAS)
Patient charities set out a shared vision for the next VPAS scheme. Cancer52 have joined forces with the Charity Medicines Access...
A joint statement on the voluntary scheme for branded medicines pricing and access (VPAS)
National Data Opt-out and what it means to cancer patients
Cancer Strategy recommendations grid April
Briefing paper on the New Cancer Drug Fund Operating Model
Briefing paper on England Cancer Strategy Implementation Plan
Briefing paper on Access to Medicines and Treatments
Policy briefing on Achieving World Class Outcomes
Briefing paper on Access to Orphan Medicines in the UK
Briefing paper on the UK Strategy for Rare Diseases: Making sure that rare cancers aren’t written ou
Briefing paper on NICE and Value Based Assessment (VBA)